Chong Kun Dang makes antidiabetic ‘Duvimet XR Tab’ smaller
Chong Kun Dang(CEO Young-Joo Kim) announced on the 3rd that the company has launched a new product with enhanced convenience by downsizing ‘Duvimet XR Tab,’ a combination drug for the treatment of diabetes.
Duvimet XR Tab is an incrementally modified drug improvement in antidiabetic efficacy and...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.